Pancreatic Cancer Research

Clinical trialNAUnknown

Re-irradiation With Stereotactic Body Radiotherapy for Relapsed Pancreatic Cancer

The Safety and Efficacy of Re-irradiation With Stereotactic Body Radiotherapy for Relapsed Pancreatic Cancer

NCT02745847↗ ClinicalTrials.gov, retrieved 4 November 2026

Outcome
Outcome unknown
Phase
NA
Status
Unknown
Study type
Interventional
Start
May 2016
Expected end
December 2023
Enrollment
30 participants
Sites
1
Primary outcomes
The toxicities following SBRT will be determined.
Sponsor
Other
Results posted
No
Last update
25 May 2023

These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Papers 8